Structure-based design of an agonistic peptide targeting Fas
A Yoshimori1, R Takasawa, A Hayakawa
1Research Institute for Biological Sciences, Tokyo University of Science, 2669 Yamazaki Noda, Chiba, 278-0022, Japan.
Summary
Researchers discovered FRAP-4, a peptide that mimics Fas ligand (FasL) to induce cancer cell death. This peptide shows promise for developing new cancer therapeutics targeting the Fas pathway.
Area of Science:
- Molecular Biology
- Computational Chemistry
- Oncology
Background:
- The Fas pathway is a critical regulator of apoptosis.
- Developing targeted therapies for cancer remains a significant challenge.
- Peptide-based drugs offer potential for specific molecular interactions.
Purpose of the Study:
- To discover and characterize a novel peptide agonist for the human Fas molecule.
- To evaluate the therapeutic potential of this peptide in cancer treatment.
- To explore a new computational method for peptide drug design.
Main Methods:
- Computer screening using the Amino acid Complement Wave (ACW) method.
- In silico molecular docking studies.
- In vitro apoptosis induction assays in ovarian cancer cells.
- Western blot analysis for caspase and PARP cleavage.
Main Results:
- A peptide, FRAP-4, was identified that binds to the human Fas molecule.
- An octamer of FRAP-4, (FRAP-4)8-MAP, induced apoptosis in NOS4 ovarian cancer cells.
- Apoptosis was mediated by caspase-8, -9, and -3 activation and PARP cleavage.
- The N-terminal tryptophan residue of FRAP-4 is crucial for Fas binding and activity.
Conclusions:
- FRAP-4 acts as a Fas ligand mimetic, effectively inducing apoptosis in cancer cells.
- The ACW method is a viable strategy for designing structure-based peptide agonists.
- (FRAP-4)8-MAP represents a promising lead for developing novel Fas-targeted cancer therapeutics.
Related Concept Videos
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...